Evidence map›Paper›PMID 39587835›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

RNA N

Dongjun Jang, Chanwoong Hwa, Seoyeon Kim, Jaeik Oh, Seungjae Shin, Soo-Jin Lee, Jiwon Kim, Sang Eun Lee, Yoojin Yang, Dohee Kim and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. The Role of NMedComm · 2026
    Review
  4. Review
  5. Review
  6. RNA mCell biology and toxicology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. YTHDFs as radiotherapy checkpoints in tumor immunity.The Journal of experimental medicine · 2025
    Review
  12. Review
  13. RNA NAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dongjun JangDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Chanwoong HwaL-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, 02841, South Korea.
Seoyeon KimL-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, 02841, South Korea.
Jaeik OhDepartment of Translational Medicine, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Seungjae ShinDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Soo-Jin LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Jiwon KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Sang Eun LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Yoojin YangDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Dohee KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Seoho LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Hae Rim JungMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Yumi OhMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Kyunggon KimDepartment of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
Hye Seung LeeDepartment of Pathology, Seoul National University College of Medicine, Seoul, 03080, South Korea.
Joon-Yong AnL-HOPE Program for Community-Based Total Learning Health Systems, Korea University, Seoul, 02841, South Korea.
Sung-Yup ChoDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 03080, South Korea.ORCID https://orcid.org/0000-0002-2720-6952

Funding

National Research Foundation of Korea 2021R1A2C3008021National Research Foundation of Korea NRF-2019M3E5D3073568National Research Foundation of Korea RS-2023-00222687National Research Foundation of Korea RS-2024-00405619Seoul National University 800-20230479
6 · The paper itself

Abstract

Immunotherapy holds potential as a treatment for gastric cancer (GC), though immune checkpoint inhibitor (ICI) resistance remains an obstacle. One resistance mechanism involves defects in interferon-γ (IFN-γ) signaling, in which IFN-γ is linked to improved responsiveness to ICIs. Herein, the roles of RNA N

Indexed as

Interferon-gammaRNA-Binding ProteinsRNA Splicing FactorsStomach NeoplasmsAdenosineAnimalsCell Line, TumorDown-RegulationFemaleGene Expression Regulation, NeoplasticHumansInterferon Regulatory Factor-1MiceSignal TransductionAdenosineInterferon-gammaInterferon Regulatory Factor-1N-methyladenosineRNA-Binding ProteinsRNA Splicing FactorsYTHDF1 protein, humanYTHDF2 protein, humancancer immunitygastric cancerinterferon‐γ signalingN6‐methyladenosineYTHDF proteins

Identifiers

PMID39587835
PMCPMC11744580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.